Results 151 to 160 of about 795 (185)
Some of the next articles are maybe not open access.
Eldecalcitol Is Less Effective in Suppressing Parathyroid Hormone Compared to Calcitriol in Vivo
Journal of Steroid Biochemistry and Molecular Biology, 2010Eldecalcitol is a vitamin D3 analog under clinical development for the treatment of osteoporosis. Previous studies have shown that the binding activities of eldecalcitol to the serum vitamin D binding protein (DBP) and the vitamin D receptor (VDR) are 421.9% and 44.6% of those of calcitriol, respectively, and also, suppressed parathyroid hormone (PTH ...
Hitoshi Saito +2 more
exaly +3 more sources
Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx‐1
Oral Diseases, 2021Abstract Objectives This study aimed to investigate the role of eldecalcitol in the progression of oral squamous cell carcinoma and to explore the related mechanism. Materials and Methods The effects of eldecalcitol ...
Yupu Lu +6 more
openaire +2 more sources
Clinical calcium, 2011
ED-71 is a new vitamin D receptor ligand, bearing a hydroxypropoxy substituent at the 2β-position of 1α, 25 (OH) (2)D(3). In ovariectomized rats, ED-71 increased vertebral bone mass and bone strength by inhibiting bone resorption and maintaining bone formation.
Itsuro, Endo, Toshio, Matsumoto
openaire +1 more source
ED-71 is a new vitamin D receptor ligand, bearing a hydroxypropoxy substituent at the 2β-position of 1α, 25 (OH) (2)D(3). In ovariectomized rats, ED-71 increased vertebral bone mass and bone strength by inhibiting bone resorption and maintaining bone formation.
Itsuro, Endo, Toshio, Matsumoto
openaire +1 more source
Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment levels
Current Medical Research and Opinion, 2012Three-year treatment with eldecalcitol has been shown to improve lumbar and total hip bone mineral density (BMD), decrease bone turnover markers, and lower the incidences of vertebral and wrist fractures in patients with osteoporosis more than with treatment with alfacalcidol under vitamin D repletion. The purpose of this study was to determine whether
Masataka, Shiraki +2 more
openaire +2 more sources
D-Hormone Derivatives for the Treatment of Osteoporosis: From Alfacalcidol to Eldecalcitol
Mini-Reviews in Medicinal Chemistry, 2009Many readers may have only a vague idea about vitamin D. This is made complicated, in part, because it is also expressed with suffixes such as vitamin D(2) or vitamin D(3). Otherwise the prefix of "active" is also occasionally used. Vitamin D is often referred to as an important nutrient for calcium intake, especially for growing children and the ...
openaire +2 more sources
Osteoporosis Treatment by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan
Current Osteoporosis Reports, 2012Although vitamin D is used mainly as a nutritional supplement in osteoporosis treatment, its active form, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], has an effect to maintain bone remodeling balance as well. Eldecalcitol is an analog of 1,25(OH) (2)D(3) with stronger effects than its native form in improving bone remodeling balance and increasing bone ...
openaire +2 more sources
Highly Stereoselective and Scalable Synthesis of Eldecalcitol
Organic Preparations and Procedures International, 2023Xue-yan Zhu +4 more
openaire +1 more source